However, administration of S1P1 agonist in SphK2−/− mice markedly suppressed CFTR expression, abolished the protective effect of SphK2 deficiency on small airways remodeling and pulmonary inflammation after CS exposure. This evidence concerns the gene S1PR1 and Cowden syndrome 1.